Close

Repligen (RGEN) Reports In-Line Q3 EPS

November 5, 2015 9:27 AM EST

Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.08, in-line with the analyst estimate of $0.08. Revenue for the quarter came in at $19.8 million versus the consensus estimate of $20.5 million.

For earnings history and earnings-related data on Repligen (RGEN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings